FDA — authorised 26 June 1996
- Marketing authorisation holder: GILEAD SCIENCES INC
- Status: approved
🇺🇸 Vistide in United States
FDA authorised Vistide on 26 June 1996
Marketing authorisations
FDA — authorised 27 June 2012
- Application: ANDA201276
- Marketing authorisation holder: MYLAN INSTITUTIONAL
- Status: approved
FDA — authorised 26 July 2012
- Application: ANDA202501
- Marketing authorisation holder: AVET LIFESCIENCES
- Local brand name: CIDOFOVIR
- Indication: SOLUTION — INTRAVENOUS
- Status: approved
Vistide in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Vistide approved in United States?
Yes. FDA authorised it on 26 June 1996; FDA authorised it on 27 June 2012; FDA authorised it on 26 July 2012.
Who is the marketing authorisation holder for Vistide in United States?
GILEAD SCIENCES INC holds the US marketing authorisation.